Evidence map›Paper›PMID 34205637›Full record

ArticleInternational journal of environmental research and public health2021

Clinical and Therapeutic Characteristics of Cancer Patients in the Southern Region of Saudi Arabia: A Cross-Sectional Study.

Hamad S Alyami, Abdallah Y Naser, Eman Zmaily Dahmash, Mohammad H Alyami, Osamah M Belali, Ahmad M Assiri, Amjad Rehman, Abdulrhman M Alsaleh, Hind A Alsaleh, Shahad H Hussein and 3 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Root Bark Extract ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hamad S AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66262, Saudi Arabia.ORCID 0000-0003-3513-4976
Abdallah Y NaserDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.ORCID 0000-0001-8440-7446
Eman Zmaily DahmashDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.
Mohammad H AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66262, Saudi Arabia.
Osamah M BelaliPharmaceutical Services Department, Asir Central Hospital, Abha 62529, Saudi Arabia.ORCID 0000-0002-7897-2243
Ahmad M AssiriPharmaceutical Services Department, Asir Central Hospital, Abha 62529, Saudi Arabia.
Amjad RehmanOncology Department, Asir Central Hospital, Abha 62529, Saudi Arabia.
Abdulrhman M AlsalehCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Hind A AlsalehCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Shahad H HusseinCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Shahad M AmerCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Sara A AsiriCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Amjad I AlmuadiCollege of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsDue to the continuous changes in modern lifestyle and the need to explore the effect of these changes on the risk of developing cancer, ongoing research on the epidemiology and characteristics of cancer patients is requested. This study explored the epidemiology of cancer, its characteristics, treatment patterns, and risk factors in the southern region of Saudi Arabia.

methodsA retrospective cross-sectional study was conducted using cancer patients' medical records at Asir Central Hospital in the southern region of Saudi Arabia. Active patients' records were extracted between January 2013 and December 2019.

resultsA total of 2038 patients were identified during the study period, with a mean age of 60.9 (SD: 19.0) years. The patients had survived with their cancer for a median duration of 4 years (IQR: 2-6). Around 4.6% of the patients required ICU admission with a median period of 9 days (IQR: 5-14.75). The death rate during the study period was 10.9%. Around 20.8% of the cases were metastatic, of which 77.8% were at stage four of metastasis, and 19.7% of the patients were receiving chemotherapy for their disease. The most common types of cancer were malignant neoplasms of digestive organs, comprising 40.8% of the sample. Older age (60 years and above) and using specific chronic disease medications were predictors associated with a higher risk of death due to cancer (

conclusionBreast, colon, and liver cancers were the most prevalent in the southern region of Saudi Arabia. Several modifiable cancer risk factors were identified. The results of this study should support decision-makers in the initiation of programs for key modifiable risk factors that enhance lifestyle changes and reduce cancer risks.

Indexed as

NeoplasmsAgedCross-Sectional StudiesHumansMiddle AgedRetrospective StudiesRisk FactorsSaudi ArabiaAsircancerepidemiologySaudi Arabia

Identifiers

PMID34205637
PMCPMC8296400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.